ElevateBio
David Hallal is the current CEO and Chairman at ElevateBio. Prior to this, they were the CEO at iTeos Therapeutics SA, and before that they held various commercial leadership roles at Amgen, Biogen, and Eyetech Pharmaceuticals. David started their career as a sales representative at The Upjohn Company in 1988.
Some individuals on their team include Agustin Melian - Chief Development Officer , Doug Chambers - VP, Quality, and Mitchell H. Finer - Chief Scientific Officer.
This person is not in any offices
ElevateBio
5 followers
ElevateBio is creating and operating a portfolio of cell and gene therapy companies through partnerships with the world’s most innovative scientists and inventors.